Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check3 days agoChange DetectedMelanoma tag was added and related topics such as MedlinePlus Genetics were included. The revision note was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page footer now shows Revision: v3.4.1, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedMelanoma and the MedlinePlus Genetics topic were removed from the page's related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Melanoma as a topic and a Related Topics link to MedlinePlus Genetics on the study page.SummaryDifference0.1%

- Check54 days agoChange DetectedExpanded the Locations section to include a comprehensive list of participating sites across multiple states and added a Revision: v3.3.3 tag. Removed the prior state-specific location blocks and the HHS Vulnerability Disclosure section.SummaryDifference2%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.